☰

Gabriel J. Villares, Ph.D. - Publications

Affiliations: 
2009 The University of Texas Graduate School of Biomedical Sciences at Houston 
Area:
Molecular Biology, Oncology
Tree Info Grants Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Rosero RA, Villares GJ, Bar-Eli M. Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection. Frontiers in Genetics. 7: 112. PMID 27379162 DOI: 10.3389/Fgene.2016.00112  0.64
2016 Shoshan E, Braeuer RR, Kamiya T, Mobley AK, Huang L, Vasquez ME, Velazquez-Torres G, Chakravarti N, Ivan C, Prieto VG, Villares GJ, Bar-Eli M. NFAT1 directly regulates IL-8 and MMP-3 to promote melanoma tumor growth and metastasis. Cancer Research. PMID 27013197 DOI: 10.1158/0008-5472.Can-15-2511  0.695
2013 Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, et al. Src activation by β-adrenoreceptors is a key switch for tumour metastasis. Nature Communications. 4: 1403. PMID 23360994 DOI: 10.1038/Ncomms2413  0.61
2013 Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, et al. Erratum: Corrigendum: Src activation by β-adrenoreceptors is a key switch for tumour metastasis Nature Communications. 4. DOI: 10.1038/Ncomms2903  0.555
2012 Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, Colin D, Bar-Eli M. Retraction Note: Targeting EGFR in bladder cancer World Journal of Urology. 30: 723-723. PMID 22972001 DOI: 10.1007/S00345-012-0940-Z  0.553
2011 Zigler M, Kamiya T, Brantley EC, Villares GJ, Bar-Eli M. PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Research. 71: 6561-6. PMID 22009534 DOI: 10.1158/0008-5472.Can-11-1432  0.7
2011 Nick AM, Stone RL, Armaiz-Pena G, Ozpolat B, Tekedereli I, Graybill WS, Landen CN, Villares G, Vivas-Mejia P, Bottsford-Miller J, Kim HS, Lee JS, Kim SM, Baggerly KA, Ram PT, et al. Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death. Journal of the National Cancer Institute. 103: 1596-612. PMID 21957230 DOI: 10.1093/Jnci/Djr372  0.47
2011 Zigler M, Villares GJ, Dobroff AS, Wang H, Huang L, Braeuer RR, Kamiya T, Melnikova VO, Song R, Friedman R, Alani RM, Bar-Eli M. Expression of Id-1 is regulated by MCAM/MUC18: a missing link in melanoma progression. Cancer Research. 71: 3494-504. PMID 21467165 DOI: 10.1158/0008-5472.Can-10-3555  0.681
2011 Villares GJ, Zigler M, Bar-Eli M. The emerging role of the thrombin receptor (PAR-1) in melanoma metastasis--a possible therapeutic target. Oncotarget. 2: 8-17. PMID 21378407 DOI: 10.18632/Oncotarget.211  0.69
2011 Villares GJ, Zigler M, Dobroff AS, Wang H, Song R, Melnikova VO, Huang L, Braeuer RR, Bar-Eli M. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype. Proceedings of the National Academy of Sciences of the United States of America. 108: 626-31. PMID 21187389 DOI: 10.1073/Pnas.1006886108  0.705
2011 Braeuer RR, Zigler M, Villares GJ, Dobroff AS, Bar-Eli M. Transcriptional control of melanoma metastasis: the importance of the tumor microenvironment. Seminars in Cancer Biology. 21: 83-8. PMID 21147226 DOI: 10.1016/J.Semcancer.2010.12.007  0.699
2011 Pena GNA, Stone RL, Nick AM, Villares GJ, Cruz A, Vivas-Mejias P, Wu Z, English RD, Soman KV, Deavers MT, Zien A, Soldatos T, Jackson DB, Wiktorowicz JE, Torres-Lugo M, et al. Abstract 937: Molecular dynamics of SrcS17 activation in chronic stress-induced tumor growth Cancer Research. 71: 937-937. DOI: 10.1158/1538-7445.Am2011-937  0.645
2010 Melnikova VO, Dobroff AS, Zigler M, Villares GJ, Braeuer RR, Wang H, Huang L, Bar-Eli M. CREB inhibits AP-2alpha expression to regulate the malignant phenotype of melanoma. Plos One. 5: e12452. PMID 20805990 DOI: 10.1371/Journal.Pone.0012452  0.587
2010 Zigler M, Villares GJ, Dobroff AS, Braeuer RR, Wang H, Huang L, Alani RM, Bar-Eli M. Abstract 2369: The adhesion molecule MCAM/MUC18 regulates the expression of Id-1 and contributes to melanoma invasion and metastasis Cancer Research. 70: 2369-2369. DOI: 10.1158/1538-7445.Am10-2369  0.694
2010 Dobroff AS, Melnikova VO, Villares GJ, Zigler M, Braeuer RR, Wang H, Huang L, Bar-Eli M. Abstract 2353: CREB regulates AP-2α transcription to determine the malignant phenotype of melanoma Cancer Research. 70: 2353-2353. DOI: 10.1158/1538-7445.Am10-2353  0.657
2010 Nick AM, Stone RL, Spannuth WA, Landen CN, Villares G, Armaiz-Pena G, Carroll AR, Ozpolat B, Tekedereli I, Vivas-Mejia P, Coleman RL, Lopez-Berestein G, Sood AK. Abstract 1044: Silencing p130cas in ovarian carcinoma induces autophagic cell death Cancer Research. 70: 1044-1044. DOI: 10.1158/1538-7445.Am10-1044  0.465
2009 Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung MC, Bar-Eli M. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. The Journal of Biological Chemistry. 284: 28845-55. PMID 19703903 DOI: 10.1074/Jbc.M109.042150  0.707
2009 Villares GJ, Dobroff AS, Wang H, Zigler M, Melnikova VO, Huang L, Bar-Eli M. Overexpression of protease-activated receptor-1 contributes to melanoma metastasis via regulation of connexin 43. Cancer Research. 69: 6730-7. PMID 19679555 DOI: 10.1158/0008-5472.Can-09-0300  0.697
2009 Dobroff AS, Wang H, Melnikova VO, Villares GJ, Zigler M, Huang L, Bar-Eli M. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma. The Journal of Biological Chemistry. 284: 26194-206. PMID 19632997 DOI: 10.1074/Jbc.M109.019836  0.71
2009 Armaiz-Pena G, Villares G, Han L, Lin Y, Sanguino A, Deavers M, Gallick G, Bar-Eli M, Lopez-Berestein G, Cole S, Lutgendorf S, Sood A. 5. Molecular mechanisms of Src activation in chronic stress-induced cancer growth Brain, Behavior, and Immunity. 23: S26. DOI: 10.1016/J.Bbi.2009.06.010  0.571
2008 Melnikova VO, Villares GJ, Bar-Eli M. Emerging roles of PAR-1 and PAFR in melanoma metastasis. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 1: 103-11. PMID 19308689 DOI: 10.1007/S12307-008-0002-7  0.687
2008 Villares GJ, Zigler M, Wang H, Melnikova VO, Wu H, Friedman R, Leslie MC, Vivas-Mejia PE, Lopez-Berestein G, Sood AK, Bar-Eli M. Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Research. 68: 9078-86. PMID 18974154 DOI: 10.1158/0008-5472.Can-08-2397  0.683
2008 Zigler M, Villares GJ, Lev DC, Melnikova VO, Bar-Eli M. Tumor immunotherapy in melanoma: strategies for overcoming mechanisms of resistance and escape. American Journal of Clinical Dermatology. 9: 307-11. PMID 18717605 DOI: 10.2165/00128071-200809050-00004  0.625
2008 Kuwai T, Nakamura T, Sasaki T, Kim SJ, Fan D, Villares GJ, Zigler M, Wang H, Bar-Eli M, Kerbel RS, Fidler IJ. Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitors. Neoplasia (New York, N.Y.). 10: 489-500. PMID 18472966 DOI: 10.1593/Neo.08200  0.669
2008 Merritt WM, Lin YG, Spannuth WA, Fletcher MS, Kamat AA, Han LY, Landen CN, Jennings N, De Geest K, Langley RR, Villares G, Sanguino A, Lutgendorf SK, Lopez-Berestein G, Bar-Eli MM, et al. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. Journal of the National Cancer Institute. 100: 359-72. PMID 18314475 DOI: 10.1093/Jnci/Djn024  0.576
2007 Villares GJ, Zigler M, Blehm K, Bogdan C, McConkey D, Colin D, Bar-Eli M. Targeting EGFR in bladder cancer. World Journal of Urology. 25: 573-9. PMID 17690890 DOI: 10.1007/S00345-007-0202-7  0.633
2006 Blehm KN, Spiess PE, Bondaruk JE, Dujka ME, Villares GJ, Zhao YJ, Bogler O, Aldape KD, Grossman HB, Adam L, McConkey DJ, Czerniak BA, Dinney CP, Bar-Eli M. Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4671-7. PMID 16899617 DOI: 10.1158/1078-0432.Ccr-06-0407  0.599
Show low-probability matches.